Ȩ > Publication > ±¹ Á¦

ÀÛ¼ºÀÚ :      ÀÛ¼ºÀÏ :     2009-02-25 (14:43:13)
À̸ÞÀÏ :      Á¶È¸¼ö :     17721
ȨÆäÀÌÁö :      ¾ÆÀÌÇÇ :     ***.***.***.***
±ÛÁ¦¸ñ :     Prevention and treatment of macroangiopathy: focusing on oxidative stress.
 
Diabetes Res Clin Pract. 2004 Dec;66 Suppl 1:S57-62.

Prevention and treatment of macroangiopathy: focusing on oxidative stress.

Park KG, Kim MJ, Kim HS, Lee SJ, Song DK, Lee IK.

Department of Internal Medicine, School of Medicine, Keimyung University Dongsan Medical Center, 194 Dongsan-Dong, Jung-Gu, Daegu 700-712, Republic of Korea.

Oxidative stress has been proposed to be a major cause of atherosclerosis in diabetes. Endothelial dysfunction, common in diabetes, is considered a prerequisite for atherosclerosis. We evaluated whether alpha-lipoic acid (ALA) is an effective treatment for oxidative stress-induced endothelial dysfunction. Using high resolution ultrasound techniques, we evaluated flow mediated vasodilation (FMD) of the brachial artery in 13 young healthy men with transient hypertriglyceridemia (HTG) induced by intralipid infusion and in 11 postmenopausal type 2 diabetics before and after ALA treatment. We also measured superoxide anion formation in neutrophils as a maker of oxidative stress. FMD was decreased and superoxide anion formation was increased significantly following intralipid infusion in the young healthy men. ALA treatment, however, reversed the HTG-induced endothelial dysfunction and decreased the superoxide anion formation. Similarly, treatment with ALA increased FMD and decreased superoxide anion formation in the postmenopausal type 2 diabetics. In addition, the change in FMD was negatively correlated with superoxide anion formation in young healthy men and in postmenopausal type 2 diabetics (r = -0.54, -0.65, respectively). All P values were below 0.05. In conclusion, our results demonstrate that ALA treatment improves HTG- and diabetic-induced endothelial dysfunction, possibly due to the antioxidant effect of ALA.

PMID: 15563982 [PubMed - indexed for MEDLINE]

 
 
 
name :
password :
  comment :
 
 
ÀÌÀü±Û ¸ñ·Ï »õ±Û¾²±â ÀÀ´ä±Û¾²±â ±Û¼öÁ¤Çϱ⠱ÛÁö¿ì±â ´ÙÀ½±Û



76 A transcriptional factor decoy against AP-1 suppresses TGF-beta1-induced type I collagen gene expres  2009.02.2617643
75 Circular dumbbell AP-1 and E2F decoy oligodeoxynucleotide based antiproliferative gene therapy  2009.02.2611889
74 E2F decoy oligodeoxynucleotides on neointimal hyperplasia in canine vein graft.  2009.02.2517741
73 Inhibitory effects of novel E2F decoy oligodeoxynucleotides on mesangial cell proliferation by coexp  2009.02.2522452
72 E2F decoy oligodeoxynucleotides effectively inhibit growth of human tumor cells.  2009.02.2518238
71 Advantages of the circular dumbbell decoy in gene therapy and studies of gene regulation.  2009.02.2512565
70 Dexamethasone regulates AP-1 to repress TNF-alpha induced MCP-1 production in human glomerular endot  2009.02.2524713
69 Relationship between serum adiponectin and leptin concentrations and body fat distribution.  2009.02.2515763
68 Ramipril treatment suppresses islet fibrosis in Otsuka Long-Evans Tokushima fatty rats.  2009.02.2537567
67 Inhibition of ATP-sensitive K+ channels by taurine through a benzamido-binding site on sulfonylurea  2009.02.2520593
66 Tumor necrosis factor-alpha induces fractalkine expression preferentially in arterial endothelial ce  2009.02.2517298
65 Sp1-decoy oligodeoxynucleotide inhibits high glucose-induced mesangial cell proliferation.  2009.02.2515711
64 Transcription factor decoy for AP-1 reduces mesangial cell proliferation and extracellular matrix pr  2009.02.2517077
63 SREBP-1c mediates the insulin-dependent hepatic glucokinase expression.  2009.02.2517715
62 Differential regulation of human and mouse orphan nuclear receptor small heterodimer partner promote  2009.02.2518787
61 Anti-obesity effects of alpha-lipoic acid mediated by suppression of hypothalamic AMP-activated prot  2009.02.2514845
60 Effect of antisense TGF-beta1 oligodeoxynucleotides in streptozotocin- induced diabetic rat kidney.  2009.02.2514936
59 Taurine increases glucose sensitivity of UCP2-overexpressing {beta}-cells by ameliorating mitochondr  2009.02.2514905
58 Analysis of proteome and transcriptome of tumor necrosis factor alpha stimulated vascular smooth mus  2009.02.2517501
Prevention and treatment of macroangiopathy: focusing on oxidative stress.  2009.02.2517721
[1] 2 [3][4][5]
¸ñ·Ï »õ±Û¾²±â